Peptide Therapy
BPC-157: BODY PROTECTION COMPOUND
What it is, how it works, what the research shows, common dosing protocols, and how to get pharmaceutical-grade BPC-157 through a medical provider.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC · Updated March 24, 2026
Book Consultation
WHAT IS BPC-157?
BPC-157 stands for Body Protection Compound-157. It's a synthetic peptide consisting of 15 amino acids, derived from a larger protective protein naturally found in human gastric juice. Researchers classify it as a "stable gastric pentadecapeptide" because of its unusual stability in the harsh acidic environment of the stomach.
BPC-157 was originally isolated and studied by Dr. Predrag Sikiric's research group at the University of Zagreb, Croatia, beginning in the early 1990s. Since then, over 100 peer-reviewed studies have been published examining its effects on tissue healing, inflammation, and organ protection. The vast majority of this research has been conducted in animal models.
The peptide works through several mechanisms: it upregulates growth factor expression (particularly VEGF), promotes angiogenesis (the formation of new blood vessels at injury sites), modulates the nitric oxide system, and supports the FAK-paxillin pathway, which governs cell migration to damaged tissue. The consistency of results across multiple tissue types and over 100 studies is what makes BPC-157 notable in the peptide landscape.
Unlike many compounds in the optimization world, BPC-157 isn't about performance enhancement or body composition. It's a repair molecule. The research points to a compound that helps the body heal faster and more completely from injury.
Key distinction: BPC-157 is not a steroid, not a hormone, and not a growth hormone releasing peptide. It's a signaling molecule focused on tissue repair and protection. It doesn't build muscle, alter hormone levels, or act as a performance-enhancing drug. It tells your body to repair damaged tissue more effectively.
BPC-157 BENEFITS
BPC-157 has been studied across a wide range of tissue types and injury models. The consistency of positive results across different systems is one of the compound's most compelling features.
Tendon & Ligament Healing
Accelerates repair of damaged tendons and ligaments. Studies show increased collagen synthesis, improved tendon-to-bone healing, and faster recovery from transection injuries. This is the most well-studied application of BPC-157.
Muscle Recovery
Animal models demonstrate accelerated muscle healing after crush injuries, lacerations, and systemic damage. BPC-157 promotes muscle fiber regeneration and reduces the formation of fibrotic scar tissue during healing.
Gut Healing
Derived from a gastric protein, BPC-157 shows protective and healing effects on the GI lining. Research demonstrates benefits for inflammatory bowel conditions, NSAID-induced gut damage, leaky gut, and intestinal lesions. This is where the compound's origin story and mechanism align most directly.
Joint Health
Promotes cartilage repair and reduces joint inflammation in animal models. Studies show improved outcomes in models of osteoarthritis and joint damage, likely mediated through growth factor upregulation and anti-inflammatory pathways.
Neuroprotection
Early research suggests BPC-157 supports nerve repair and protection. Studies show improved outcomes in models of peripheral nerve injury, traumatic brain injury, and spinal cord damage. It interacts with the dopaminergic system and appears to have neuroprotective properties.
Counteracts NSAID Damage
BPC-157 has been uniquely shown to reverse the gastrointestinal damage caused by NSAIDs (ibuprofen, naproxen, aspirin). For anyone who relies on anti-inflammatories for chronic pain or recovery, this is a significant finding—addressing the side effects of the very drugs commonly used for the same conditions BPC-157 targets.
Important context: Most BPC-157 research is in animal models. Human clinical trials are limited but ongoing. The consistency of results across 100+ studies and multiple tissue types is what makes BPC-157 notable — but anyone using it should understand that the human evidence base is still developing. This is a compound where the preclinical signal is strong, but the clinical confirmation is incomplete.
HOW BPC-157 WORKS
BPC-157's healing effects aren't from a single mechanism. It appears to coordinate multiple repair pathways simultaneously, which may explain why it shows benefits across so many different tissue types.
Upregulates VEGF (Vascular Endothelial Growth Factor)
BPC-157 increases VEGF expression, which drives angiogenesis — the formation of new blood vessels at injury sites. More blood vessels means more oxygen, more nutrients, and faster delivery of immune cells to damaged tissue. This is foundational to healing any injury.
Modulates the Nitric Oxide System
BPC-157 interacts with the nitric oxide (NO) pathway, producing anti-inflammatory and vasodilatory effects. It appears to normalize NO production — increasing it where needed for healing and reducing it where excess contributes to inflammation.
Activates FAK-Paxillin Pathway
The focal adhesion kinase (FAK) and paxillin signaling pathway governs cell migration and adhesion. BPC-157 activates this pathway, directing cells to migrate to injury sites and adhere to damaged tissue — essentially telling repair cells where to go and where to attach.
Promotes Collagen Synthesis
Studies show BPC-157 enhances growth hormone receptor expression in tendon fibroblasts, leading to increased collagen production. Collagen is the structural protein in tendons, ligaments, and connective tissue — more collagen synthesis means stronger, faster structural repair.
Protects Endothelium
BPC-157 demonstrates protective effects on the vascular endothelium — the lining of blood vessels. This contributes to both its healing properties (maintaining blood supply to injured tissue) and its protective effects against various forms of organ damage.
Interacts with Dopaminergic System
Research shows BPC-157 interacts with the brain-gut axis and the dopaminergic system, which may explain its neuroprotective effects. This connection between gut-derived peptides and neurological function is an active area of investigation.
BPC-157 DOSING & ADMINISTRATION
BPC-157 is administered as a subcutaneous injection. Here are the standard protocol parameters used in clinical practice:
Standard Dose
250-500mcg per day, administered as a subcutaneous injection. Can be injected near the injury site for localized effects or in the abdomen for systemic applications (gut healing, general recovery).
Cycle Length
Typically 4-12 weeks depending on injury severity and treatment goals. Acute injuries may respond in 4-6 weeks. Chronic conditions and gut healing protocols often run 8-12 weeks.
Injection Frequency
Once daily is the standard protocol. Some providers split the dose into two smaller injections per day (morning and evening) for sustained signaling, though once daily is most common.
Reconstitution
BPC-157 ships as a lyophilized (freeze-dried) powder. It's reconstituted with bacteriostatic water before use. Your provider will give you specific reconstitution instructions based on the concentration of your vial.
Storage
Refrigerate after reconstitution. Unreconstituted powder can be stored at room temperature. Ships overnight refrigerated. Once reconstituted, use within 30 days.
Vial Size
Standard vial: 5ml, 3mg/ml concentration, 15mg total. At 250mcg/day this lasts approximately 60 days (2 months). At 500mcg/day, approximately 30 days (1 month).
Note: Dosing should be determined by your provider based on your specific condition, injury type, and treatment goals. The parameters above are general ranges used in clinical practice — your protocol may differ. Self-dosing based on internet forums is how people get suboptimal results or unnecessary side effects.
BPC-157 SIDE EFFECTS & RISKS
BPC-157 has a favorable safety profile in the published research. No serious adverse events have been reported across 100+ studies. That said, here's what to know:
Common (mild): Injection site redness or irritation. This is the most frequently reported effect and typically resolves within minutes to hours. Rotating injection sites helps minimize this.
Less common: Nausea, dizziness, or headache. These are rare at standard therapeutic doses (250-500mcg/day) and when they occur, they're typically mild and transient.
Serious adverse events: None reported in published research. BPC-157 has not shown toxicity at doses far exceeding therapeutic ranges in animal studies. No organ damage, no hormonal disruption, no carcinogenic signals.
Important caveat: Side effect data comes primarily from animal studies. The limited human data available has not shown significant safety concerns, but long-term human safety data is still being established. This is an honest limitation of the current evidence base.
The biggest risk isn't BPC-157 itself — it's the source. Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide. When you inject something, what's in the vial matters more than what's on the label. More on sourcing below.
WHO IS BPC-157 FOR?
BPC-157 is a targeted therapy for tissue repair and recovery. It's most appropriate for people dealing with specific injuries or conditions, not as a general wellness supplement.
Good Candidates
Athletes recovering from tendon/ligament injuries — Achilles tendonitis, rotator cuff issues, tennis elbow, patellar tendinopathy. This is BPC-157's strongest studied application.
Chronic joint pain — Persistent joint issues that haven't fully resolved with physical therapy, rest, or standard anti-inflammatory treatment.
Gut issues — IBS, leaky gut, NSAID-related GI damage, and chronic intestinal inflammation. BPC-157's gastric origin makes this a particularly logical application.
Post-surgical recovery — Accelerating healing after orthopedic surgery, soft tissue repairs, or procedures where tissue recovery is the limiting factor.
Chronic inflammation — Conditions where persistent inflammation is driving tissue damage or slowing recovery.
Who Should Avoid BPC-157
Pregnant or nursing women — Insufficient safety data in pregnancy and lactation. Standard precaution for any peptide therapy.
Active cancer patients — BPC-157 promotes angiogenesis (new blood vessel growth). In theory, this could support tumor vascularization. While no evidence links BPC-157 to cancer progression, the precautionary principle applies.
History of hormone-sensitive conditions — As a precaution, until more human data is available. Your provider will screen for contraindications.
Bottom line: BPC-157 is a precision tool for recovery, not a general performance enhancer. If you have a specific injury or gut issue that hasn't resolved with standard treatment, it's worth discussing with a provider who works with peptides.
HOW TO GET BPC-157
BPC-157 is available through 503A compounding pharmacies with a valid prescription from a licensed medical provider. Understanding the regulatory landscape helps clarify what's legal, what's not, and why sourcing matters.
The 503A vs. 503B Distinction
The FDA's 2024 decision removed BPC-157 from 503B outsourcing facility eligibility. 503B facilities produce bulk quantities of compounded medications without patient-specific prescriptions. 503A compounding pharmacies operate differently — they fill individual prescriptions for specific patients, under direct provider oversight. Patient-specific 503A compounding operates under a separate regulatory framework.
How Moonshot Medical Sources BPC-157
Moonshot Medical works with a licensed 503A compounding pharmacy that provides pharmaceutical-grade BPC-157. Every batch is tested for identity, purity, potency, and sterility. This is a fundamentally different product than what you find on "research chemical" websites.
What You Get
A pharmaceutical-grade compound with verified purity and potency. A personalized dosing protocol based on your specific condition. Medical oversight throughout your treatment cycle. This is the difference between "I'm injecting something I bought online" and "I'm on a managed therapeutic protocol."
"Research chemical" websites are not the same thing. Peptides sold online as "for research purposes only" are not manufactured under pharmaceutical standards, not tested for human use, and may contain incorrect substances, wrong concentrations, or contamination. There's no quality assurance and no way to verify what you're injecting. The price might be lower, but the risk is categorically different.
BPC-157 COST AT MOONSHOT MEDICAL
Transparent pricing. No hidden fees. Here's what BPC-157 therapy costs at Moonshot Medical in Park Ridge, IL:
$250/mo
BPC-157 therapy — pharmaceutical-grade compound from a licensed 503A compounding pharmacy
Included
Medical oversight, personalized dosing protocol, injection training, and monitoring throughout treatment
Not Covered
Insurance does not cover peptide therapy — it's a cash-pay service at all clinics, not just ours
An initial consultation is required before starting BPC-157 therapy. This is where we review your medical history, discuss your injury or condition, determine if BPC-157 is appropriate, and build your dosing protocol.
See our full peptide therapy services and pricing page for details on all available peptides.
BPC-157 FAQ
What is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids, derived from a protective protein found in human gastric juice. It has been studied extensively in animal models for its ability to accelerate healing of tendons, ligaments, muscle, gut lining, and nerve tissue. It works by upregulating growth factor expression, promoting angiogenesis, and modulating the nitric oxide system.
Is BPC-157 legal?
Yes — BPC-157 is available through 503A compounding pharmacies with a valid prescription from a licensed medical provider. The FDA's 2024 decision removed BPC-157 from 503B outsourcing facility (bulk manufacturing) eligibility, but 503A patient-specific compounding operates under a different regulatory framework. Moonshot Medical works with a licensed 503A compounding pharmacy to provide pharmaceutical-grade BPC-157.
How long does BPC-157 take to work?
Many patients notice improvement within 1-2 weeks, particularly reduced pain and improved mobility at injury sites. Full therapeutic effects typically develop over 4-12 weeks depending on the severity and type of injury. Gut healing applications may show results within the first 2-4 weeks. Chronic, long-standing injuries generally take longer than acute ones.
Can I take BPC-157 orally?
Some research supports oral use of BPC-157, especially for gut healing — which makes biological sense given that it's derived from a gastric protein. However, subcutaneous injection is the standard route for systemic and musculoskeletal effects, as it provides more reliable bioavailability and allows injection near the injury site for localized effects.
How much does BPC-157 cost?
At Moonshot Medical in Park Ridge, IL, BPC-157 costs $250 per month. This includes the pharmaceutical-grade compound from a licensed 503A compounding pharmacy, medical oversight, a personalized dosing protocol, and monitoring. Insurance does not cover peptide therapy.
Is BPC-157 the same as steroids?
No. BPC-157 is a signaling peptide — a short chain of amino acids that promotes tissue repair and reduces inflammation. It is not a steroid, not a hormone, and not a growth hormone releasing peptide. Steroids are synthetic hormones that directly supply exogenous hormones. BPC-157 works by upregulating your body's own healing mechanisms. Different compound, different mechanism, different risk profile.
References
- 1. Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Curr Pharm Des. 2011;17(16):1612-32.
- 2. Sikiric P, et al. "Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications." Curr Neuropharmacol. 2016;14(8):857-865.
- 3. Chang CH, et al. "BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts." Molecules. 2014;19(11):19066-77.
- 4. Staresinic M, et al. "Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth." J Orthop Res. 2003;21(6):976-83.
- 5. Seiwerth S, et al. "BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing." Curr Pharm Des. 2018;24(18):1972-1989.
INTERESTED IN BPC-157?
Book a consultation to find out if BPC-157 is right for your recovery goals.
Book Consultation